United States Psychedelic Mushroom Market to Grow with a CAGR of 11.30% through 2029
Supportive legislation, investment, and rising patient
demand is expected to drive the United States Psychedelic Mushroom Market
growth in the forecast period, 2025-2029.
According to TechSci Research report, “United
States Psychedelic Mushroom Market – By Region, Competition, Forecast and
Opportunities, 2019-2029F”, the United States Psychedelic Mushroom Market stood at
USD 1809.27 million in 2023 and is anticipated to grow with a CAGR of 11.30% in
the forecast period through 2029. This can be attributed to shifting public perception.
Public perception of psychedelic mushrooms has undergone a transformation. They
are increasingly seen as a valuable tool for personal growth, mental health,
and spiritual exploration. This shift in perception is breaking down stigmas
and encouraging more individuals to explore the potential benefits of these substances.
Furthermore, regions where psychedelic substances are
legal and accessible are becoming destinations for individuals seeking
transformative experiences. Psychedelic retreat tourism is expected to grow,
with individuals traveling to these destinations to partake in guided sessions
and connect with like-minded communities.
The driving
force behind the U.S. psychedelic mushroom market stems from the growing
movement toward decriminalization of these substances. Certain cities, such as
Denver, Colorado, and Oakland, California, have enacted laws that deprioritize
the enforcement of regulations against the possession and use of psychedelic
mushrooms. Additionally, advocacy groups are actively working to reform state
and federal drug laws to enable broader access to psychedelic therapies.
Moreover, there is an expanding body of scientific research exploring the potential therapeutic advantages of psychedelic mushrooms and similar substances. Numerous clinical trials have been completed or are presently underway to assess the safety and effectiveness of these substances in treating various mental health conditions. Positive outcomes from these studies could contribute to increased mainstream acceptance of psychedelic therapies and heightened demand.
Scientific research has revealed that psilocybin can induce changes in brain activity that may alleviate symptoms of depression. Clinical trials have shown that individuals with depression who received psilocybin reported significant improvements in mood, as well as reduced anxiety and feelings of hopelessness. Compass Pathways, a mental healthcare company, conducted a trial that suggests psilocybin, the psychedelic component found in magic mushrooms, can be an effective treatment for severe depression when combined with psychotherapy.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "United States Psychedelic Mushroom Market”
The United
States Psychedelic Mushroom Market is segmented into product
type, form, application, regional distribution and company.
Based on application,
the recreational sector boasted the highest revenue in 2023. Some individuals
engage in the recreational use of psychedelic mushrooms to attain altered
states of consciousness, induce feelings of euphoria, and enhance creativity.
These mushrooms contain psilocybin, a potent hallucinogenic compound that can
induce various effects on both the mind and body. Upon ingestion, psilocybin
undergoes metabolic conversion into psilocin, which attaches to serotonin
receptors in the brain, resulting in alterations in perception, cognition, and
emotions. These effects encompass changes in sensory perception, mood
fluctuations, and shifts in consciousness. Moreover, the de-addiction aspect of
the U.S. psychedelic mushroom market is projected to experience substantial
revenue growth in the foreseeable future, as psychedelic mushrooms have been
researched as a potential remedy for depression.
Based on region, The North-East region is set to take a leading role in the United States Psychedelic Mushroom Market for several compelling reasons. This area has a strong tradition of adopting alternative and holistic health practices, including the use of natural substances such as psychedelic mushrooms. This cultural acceptance creates a supportive environment for the market's expansion. The North-East boasts numerous major cities and urban centers that serve as hubs for research institutions, medical facilities, and a diverse population. This concentration of resources and intellectual capital drives scientific research into the therapeutic benefits of psychedelic mushrooms and fosters growing interest in their mental health applications.
The North-East tends to have more progressive drug policies and regulations compared to other regions, which can ease the development and distribution of psychedelic mushroom products for both recreational and therapeutic uses. Overall, the region's cultural acceptance, extensive urban infrastructure, and favorable regulatory framework make it a prime candidate to spearhead the growth of the psychedelic mushroom market in the United States.
Major companies
operating in United States Psychedelic Mushroom Market are:
- Shroomland LA
- Galaxy Treats
- Blissmushrooms
- One Up Mushroom
- Psychedelic Mushy
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“Wellness centers focused on psychedelic experiences are projected to expand significantly. These centers will offer guided sessions conducted by trained professionals, creating a secure and supportive environment for individuals seeking personal development, spiritual exploration, or therapeutic benefits. The anticipated growth of these centers aligns with the increasing demand for structured and supervised psychedelic experiences.”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“United States Psychedelic Mushroom Market By Product Type (Psilocybe (Psilocybe cubensis, Psilocybe semilanceata, Psilocybe azurescens, Psilocybe cyanescens, Psilocybe baeocystis), Gymnopilus (Spectabilis, Others), Panaeolus), By Form (Fresh/Whole, Dried, Processed), By Application (Depression Relief, Anxiety Relief, De-addiction, Recreational, Others), By Region, By Competition Forecast & Opportunities, 2019-2029F”, has evaluated
the future growth potential of United States Psychedelic Mushroom Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United States Psychedelic Mushroom Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com